AE hepatic lesions: correlation between calcifications at CT and FDG-PET/CT metabolic activity

被引:22
|
作者
Brumpt, Eleonore [1 ]
Blagosklonov, Oleg [2 ]
Calame, Paul [1 ]
Bresson-Hadni, Solange [3 ]
Vuitton, Dominique Angele [3 ]
Delabrousse, Eric [1 ,3 ,4 ]
机构
[1] CHU Besancon, Serv Radiol, F-25000 Besancon, France
[2] CHU Besancon, Serv Med Nucl, F-250000 Besancon, France
[3] WHO Collaborating Ctr Prevent & Treatment Human E, F-25000 Besancon, France
[4] Univ Bourgogne Franche Comte, Nanomed Lab, Imagery & Therapeut, EA 4662, F-25000 Besancon, France
关键词
Alveolar echinococcosis; Calcifications; FDG-PET/CT; CT; ALVEOLAR ECHINOCOCCOSIS; FOLLOW-UP; OSTEOPONTIN; MANAGEMENT;
D O I
10.1007/s15010-019-01328-z
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose To correlate the presence of calcifications in alveolar echinococcosis (AE) hepatic lesions to the metabolic activity in 18 fluorodeoxyglucose positron emission tomography combined with computed tomography (FDG-PET/CT). Methods Our institutional review board approved this study. 61 patients (29 women, 32 men, aged from 15 to 86 years) were included in the study. Images of FDG-PET/CT were interpreted by two independent nuclear medicine physicians. AE hepatic lesions were classified as AE lesions with or without hypermetabolic activity. The presence of calcifications was assessed on unenhanced CT scans by two independent radiologists blinded with regard to the metabolic activity of the AE hepatic lesions. Every single calcification the size of which was < 3 mm and non-measurable calcifications which were forming areas with a powdery appearance were considered as microcalcifications. All other types of calcifications were reported as macrocalcifications. Statistical analysis was performed and p value < 0.05 was considered as statistically significant. Results Microcalcifications and macrocalcifications were present at CT in 95% (58/61) AE hepatic lesions and 43% (26/61) AE hepatic lesions, respectively. Hypermetabolic activity was present at FDG-PET/CT in 93% (57/61) AE hepatic lesions. 98% (56/57) of the AE hepatic lesions presenting with hypermetabolic activity at FDG-PET/CT showed microcalcifications at CT (p = 0.01) when only 40% (23/57) showed macrocalcifications at CT (p = 0.3). 100% (23/23) of the AE hepatic lesions with hypermetabolic activity at FDG-PET/CT and macrocalcifications at CT showed also microcalcifications at CT. Conclusions Hypermetabolic activity of AE hepatic lesions at FDG-PET/CT is strongly correlated to the presence of microcalcifications at CT, independently of the presence of macrocalcifications.
引用
收藏
页码:955 / 960
页数:6
相关论文
共 50 条
  • [31] Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer
    Bae, Ja Seong
    Chae, Byung Joo
    Park, Woo Chan
    Kim, Jeong Soo
    Kim, Sung Hoon
    Jung, Sang Seol
    Song, Byung Joo
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2009, 7
  • [32] Comparison of FDG-PET, MRI and CT for post radiofrequency ablation evaluation of hepatic tumors
    Chen, Wengen
    Zhuang, Hongming
    Cheng, Gang
    Torigian, Drew A.
    Alavi, Abass
    ANNALS OF NUCLEAR MEDICINE, 2013, 27 (01) : 58 - 64
  • [33] Porta Hepatic Schwannoma on FDG PET/CT
    Filizoglu, Nuh
    Oksuzoglu, Kevser
    Ozguven, Salih
    Ones, Tunc
    Erdil, Tanju Yusuf
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (07) : 575 - 576
  • [34] Hepatic Paragonimiasis Revealed by FDG PET/CT
    Cheng, Wuying
    Li, Fang
    Zhuang, Hongming
    Zhong, Dingrong
    Wu, Chenxi
    Zhu, Zhaohui
    CLINICAL NUCLEAR MEDICINE, 2010, 35 (09) : 726 - 728
  • [35] The prognostic value of preoperative FDG-PET/CT metabolic parameters in cervical cancer patients
    Bollineni V.R.
    Ytre-Hauge S.
    Gulati A.
    Halle M.K.
    Woie K.
    Salvesen Ø.
    Trovik J.
    Krakstad C.
    Haldorsen I.S.
    European Journal of Hybrid Imaging, 2 (1):
  • [36] FDG-PET/CT in Inflammatory Bowel Disease: Is There a Future?
    Brodersen, Jacob Broder
    Hess, Soren
    PET CLINICS, 2020, 15 (02) : 153 - +
  • [37] FDG-PET/CT in infections: the imaging method of choice?
    Glaudemans, Andor W. J. M.
    Signore, Alberto
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (10) : 1986 - 1991
  • [38] Weight loss as primary indication for FDG-PET/CT
    Maliha, Peter George
    Singerman, Julia
    Probst, Stephan
    NUCLEAR MEDICINE COMMUNICATIONS, 2020, 41 (10) : 1066 - 1072
  • [39] FDG-PET/CT for diagnosis of primary ovarian cancer
    Kitajima, Kazuhiro
    Suzuki, Kayo
    Senda, Michio
    Kita, Masato
    Nakamoto, Yuji
    Onishi, Yumiko
    Maeda, Tetsuo
    Yoshikawa, Takeshi
    Ohno, Yoshiharu
    Sugimura, Kazuro
    NUCLEAR MEDICINE COMMUNICATIONS, 2011, 32 (07) : 549 - 553
  • [40] Importance of FDG-PET/CT for surgery of rectal cancer
    Wiegering, A.
    Herrmann, K.
    Bluemel, C.
    Buck, A. K.
    Germer, C. -T.
    CHIRURG, 2014, 85 (06): : 487 - 492